JP2024516769A5 - - Google Patents

Info

Publication number
JP2024516769A5
JP2024516769A5 JP2023556501A JP2023556501A JP2024516769A5 JP 2024516769 A5 JP2024516769 A5 JP 2024516769A5 JP 2023556501 A JP2023556501 A JP 2023556501A JP 2023556501 A JP2023556501 A JP 2023556501A JP 2024516769 A5 JP2024516769 A5 JP 2024516769A5
Authority
JP
Japan
Application number
JP2023556501A
Other languages
Japanese (ja)
Other versions
JP7574467B2 (ja
JPWO2022195028A5 (https=
JP2024516769A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/057029 external-priority patent/WO2022195028A2/en
Publication of JP2024516769A publication Critical patent/JP2024516769A/ja
Publication of JP2024516769A5 publication Critical patent/JP2024516769A5/ja
Publication of JPWO2022195028A5 publication Critical patent/JPWO2022195028A5/ja
Priority to JP2024180571A priority Critical patent/JP2025011259A/ja
Application granted granted Critical
Publication of JP7574467B2 publication Critical patent/JP7574467B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023556501A 2021-03-18 2022-03-17 治療用結合分子 Active JP7574467B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024180571A JP2025011259A (ja) 2021-03-18 2024-10-16 治療用結合分子

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163162603P 2021-03-18 2021-03-18
US63/162,603 2021-03-18
PCT/EP2022/057029 WO2022195028A2 (en) 2021-03-18 2022-03-17 Therapeutic binding molecules

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024180571A Division JP2025011259A (ja) 2021-03-18 2024-10-16 治療用結合分子

Publications (4)

Publication Number Publication Date
JP2024516769A JP2024516769A (ja) 2024-04-17
JP2024516769A5 true JP2024516769A5 (https=) 2024-05-23
JPWO2022195028A5 JPWO2022195028A5 (https=) 2024-05-23
JP7574467B2 JP7574467B2 (ja) 2024-10-28

Family

ID=81327268

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023556501A Active JP7574467B2 (ja) 2021-03-18 2022-03-17 治療用結合分子
JP2024180571A Pending JP2025011259A (ja) 2021-03-18 2024-10-16 治療用結合分子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024180571A Pending JP2025011259A (ja) 2021-03-18 2024-10-16 治療用結合分子

Country Status (19)

Country Link
US (3) US12049506B2 (https=)
EP (2) EP4308607A2 (https=)
JP (2) JP7574467B2 (https=)
KR (2) KR20250069981A (https=)
CN (1) CN116997571A (https=)
AR (1) AR125142A1 (https=)
AU (2) AU2022236492B2 (https=)
CA (1) CA3212630A1 (https=)
CL (1) CL2023002759A1 (https=)
CO (1) CO2023013566A2 (https=)
CR (1) CR20230488A (https=)
EC (1) ECSP23078844A (https=)
IL (2) IL305690B2 (https=)
MA (1) MA71643A (https=)
MX (1) MX2023010917A (https=)
NZ (1) NZ804536A (https=)
TW (1) TWI872319B (https=)
WO (1) WO2022195028A2 (https=)
ZA (1) ZA202309418B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA53338A (fr) * 2018-03-05 2022-01-05 Janssen Pharmaceutica Nv Dosages pour détecter la neurodégénérescence
EP4417623A1 (en) * 2023-02-15 2024-08-21 Fundació Institut de Recerca Contra la Leucèmia Josep Carreras Ccr9 targeting moiety for the treatment of ccr9-positive cancer
EP4578874A1 (en) 2023-12-29 2025-07-02 SunRock Biopharma S.L. Anti-ccr9 antibody

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB2183661B (en) 1985-03-30 1989-06-28 Marc Ballivet Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique
US6492107B1 (en) 1986-11-20 2002-12-10 Stuart Kauffman Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
DE3600905A1 (de) 1986-01-15 1987-07-16 Ant Nachrichtentech Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
CA2016841C (en) 1989-05-16 1999-09-21 William D. Huse A method for producing polymers having a preselected activity
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
WO1990014443A1 (en) 1989-05-16 1990-11-29 Huse William D Co-expression of heteromeric receptors
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
ATE300615T1 (de) 1990-08-29 2005-08-15 Genpharm Int Transgene mäuse fähig zur produktion heterologer antikörper
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
CA2405246A1 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with alterred binding properties
ES2341666T3 (es) 1991-12-02 2010-06-24 Medimmune Limited Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
EP1291360A1 (en) 1991-12-13 2003-03-12 Xoma Corporation Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
AU725609C (en) 1995-08-18 2002-01-03 Morphosys Ag Protein/(poly)peptide libraries
US6696248B1 (en) 1995-08-18 2004-02-24 Morphosys Ag Protein/(poly)peptide libraries
US5714352A (en) 1996-03-20 1998-02-03 Xenotech Incorporated Directed switch-mediated DNA recombination
ES2434961T5 (es) 1998-04-20 2018-01-18 Roche Glycart Ag Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo
US6329159B1 (en) * 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
EP1176195B1 (en) 1999-04-09 2013-05-22 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
ATE482275T1 (de) 1999-07-02 2010-10-15 Morphosys Ag Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden
HUP0600342A3 (en) 2001-10-25 2011-03-28 Genentech Inc Glycoprotein compositions
US7538195B2 (en) 2002-06-14 2009-05-26 Immunogen Inc. Anti-IGF-I receptor antibody
BR0316101A (pt) 2002-11-07 2005-09-27 Immunogen Inc Anticorpos anticd33 e processo para tratamento de leucemia melóide aguda usando os mesmos
GB0624500D0 (en) * 2006-12-07 2007-01-17 Istituto Superiore Di Sanito A novel passive vaccine for candida infections
JP5470817B2 (ja) 2008-03-10 2014-04-16 日産自動車株式会社 電池用電極およびこれを用いた電池、並びにその製造方法
SG178925A1 (en) 2009-09-22 2012-04-27 Volker Sandig Process for producing molecules containing specialized glycan structures
JP6136279B2 (ja) 2013-01-15 2017-05-31 株式会社ジェイテクト 転がり軸受装置
TWI503850B (zh) 2013-03-22 2015-10-11 Polytronics Technology Corp 過電流保護元件
TWI510996B (zh) 2013-10-03 2015-12-01 Acer Inc 控制觸控面板的方法以及使用該方法的可攜式電腦
EP2876114A1 (en) * 2013-11-25 2015-05-27 Consejo Superior De Investigaciones Científicas Antibodies against CCR9 and applications thereof
CA2874083C (en) * 2014-12-05 2024-01-02 Universite Laval Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
US9816280B1 (en) 2016-11-02 2017-11-14 Matthew Reitnauer Portable floor

Similar Documents

Publication Publication Date Title
CL2026000223A1 (es) Combinación de unidad de presecado giratoria con obtención de co2
JP2024516769A5 (https=)
BR102022025291A2 (https=)
CL2025003787A1 (es) Un aparato para operar una pistola de licor de una caldera de recuperación, una caldera de recuperación y un método de operación del aparato.
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BY13172U (https=)
BY13166U (https=)
CN307045028S (https=)
CN307046333S (https=)
CN307044813S (https=)
CN307044758S (https=)
CN307044442S (https=)
CN307046500S (https=)
CN307047699S (https=)
BY23963C1 (https=)
CN307048386S (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13161U (https=)